From Clinical Insight
to Clinical Platform
The Gap Was Everywhere
Working in a major academic medical centre, our clinical co-founder witnessed the same failure mode repeat: comprehensive data sat in the EHR, but no intelligence surfaced from it. Patients deteriorated between reviews. Aortic measurements were tracked on spreadsheets. No one owned the decision layer.
Built by the User, Not the Vendor
The founding team knew the problem from the inside. Not from a sales brochure or a McKinsey deck, but from standing at the bedside. This clinical insider access became our single most important competitive advantage. Every feature decision starts from clinical reality.
Standards-First, EHR-Agnostic
We built on FHIR R4 and SMART on FHIR open standards from day one. This means Novalytic connects to any compliant EHR system via configuration, not custom integration. One intelligence platform. Any institution. Any system.
Novalytic: Resolving Complexity
Our MVP delivers four high-acuity surveillance modules. We're deploying with pilot institutions and building the evidence base. The roadmap extends into heart failure, renal, oncology, and beyond. Every module powered by the same clinical intelligence engine.
The Unfair Advantage
McKinsey provides strategic insight. EHR vendors capture data. Nobody owns the decision layer between them.
Novalytic does.
We have direct access to real-world clinical surveillance datasets, Epic implementation knowledge from inside a major UK trust, and a founding team that has navigated institutional procurement, clinical governance, and MDT workflows, not from a consulting engagement but from doing the job.
This isn't a product built by software engineers guessing at clinical workflows. Every threshold, every alert logic, every prioritisation rule has been validated by the clinicians who will use it.